Seborrheic Keratosis Clinical Trial
- Male or female 19 and over
Seborrheic keratosis (SK) is one of the most common skin tumors in man. The non-cancerous epithelial skin tumors are most commonly seen in older individuals, increasing in prevalence with increasing age and affect men and women equally. While the growths may be single, they often occur in large numbers and can look like warts, moles or skin tags that may vary in color from flesh colored, to shades of yellow, gray, brown, or black. Though non-cancerous, SK lesions are often cosmetically worrisome to patients.
Coastal Clinical Research, Inc. (CCR) has conducted over 65 dermatology trials since 1987.
You may be eligible to participate in our seborrheic keratosis study and contribute to the development and approval of a new drug or treatment. As a participant, there is no cost to you and health insurance is not required. If you qualify, you also receive study-related visits by a board-certified dermatologist and may be compensated for time and travel.